Eyam Vaccines and Immunotherapeutics


Eyam's mission is to design and develop third generation vaccine technologies that create universal coverage and protection through our proprietary Gemini self-amplifying RNA and DNA platform. Leveraging the Jennerator Bioinformatics Platform, we are designing and testing universal vaccines to protect against COVID-19, influenza and others. On the therapeutics front, we are advancing an antibody biologic for the treatment of Leukemia and lymphoma.